NextPlat shares jump 14.20% premarket after expecting 75% sequential 340B revenue growth in Q4 2025.

NextPlat surged 14.20% in premarket trading following the announcement of a 75% sequential quarterly growth in 340B contract revenue for Q4 2025 and a strategic consulting agreement with Barreto Group. The company highlighted new business initiatives in 2025’s second half, including two secured healthcare contracts and expanded leadership under Chairman Rodney Barreto, who will oversee business development. These efforts are expected to drive over 12,000 additional 340B prescriptions, boosting quarterly volumes. The consulting agreement with Barreto, a prominent Florida business leader, further signals a strategic focus on healthcare expansion and joint ventures. These developments align with the company’s forward-looking growth projections and operational streamlining, fueling investor optimism ahead of Q4 results.